发明申请
- 专利标题： Therapy using anti-CD-19 antibodies
- 专利标题（中）： 使用抗CD-19抗体治疗
-
申请号： US10903858申请日： 2004-08-02
-
公开(公告)号： US20050070693A1公开(公告)日： 2005-03-31
- 发明人: Hans Hansen , Zhengxing Qu , David Goldenberg
- 申请人： Hans Hansen , Zhengxing Qu , David Goldenberg
- 申请人地址： US NJ Morris Plains 07950
- 专利权人： Immunomedics, Inc.
- 当前专利权人： Immunomedics, Inc.
- 当前专利权人地址： US NJ Morris Plains 07950
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K51/00 ; C07K16/00 ; C07K16/28 ; C07K16/46 ; C12N20060101
摘要：
The present invention provides humanized, chimeric and human anti-CD19 antibodies, anti-CD19 antibody fusion proteins, and fragments thereof that bind to a human B cell marker. Such antibodies, fusion proteins and fragments thereof are useful for the treatment and diagnosis of various B-cell disorders, including B-cell malignancies and autoimmune diseases.
公开/授权文献
- US07109304B2 Humanized anti-CD19 antibodies 公开/授权日：2006-09-19
信息查询
